A detailed history of Ossiam transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ossiam holds 64,398 shares of VRTX stock, worth $26.1 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
64,398
Previous 65,505 1.69%
Holding current value
$26.1 Million
Previous $30.7 Million 2.45%
% of portfolio
0.59%
Previous 0.59%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $509,220 - $559,898
-1,107 Reduced 1.69%
64,398 $30 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $21.4 Million - $26.4 Million
54,411 Added 490.45%
65,505 $30.7 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $856,149 - $936,768
2,100 Added 23.35%
11,094 $4.64 Million
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $424,634 - $508,421
1,238 Added 15.96%
8,994 $3.66 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $76,766 - $82,278
227 Added 3.02%
7,756 $2.7 Million
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $28.8 Million - $32.2 Million
-91,574 Reduced 92.4%
7,529 $2.65 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $862,152 - $983,516
3,044 Added 3.17%
99,103 $31.2 Million
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $504,366 - $567,412
1,765 Added 1.87%
96,059 $27.7 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $483,036 - $538,954
-1,764 Reduced 1.84%
94,294 $27.3 Million
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $466,160 - $580,419
1,984 Added 2.11%
96,058 $27.1 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $890,108 - $1.05 Million
4,020 Added 4.46%
94,074 $24.6 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $15.5 Million - $19.5 Million
87,369 Added 3253.97%
90,054 $19.8 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $71,286 - $79,775
393 Added 17.15%
2,685 $487,000
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $501,723 - $591,663
-2,676 Reduced 53.86%
2,292 $462,000
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $975,271 - $1.14 Million
4,711 Added 1833.07%
4,968 $1.07 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $42,437 - $56,598
205 Added 394.23%
257 $61,000
Q3 2020

Nov 12, 2020

SELL
$255.65 - $303.1 $511 - $606
-2 Reduced 3.7%
52 $14,000
Q2 2020

Aug 13, 2020

SELL
$225.48 - $295.8 $756,936 - $993,000
-3,357 Reduced 98.42%
54 $16,000
Q1 2020

May 14, 2020

BUY
$199.77 - $247.81 $570,942 - $708,240
2,858 Added 516.82%
3,411 $812,000
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $57,848 - $77,696
-347 Reduced 38.56%
553 $121,000
Q3 2019

Nov 13, 2019

BUY
$166.23 - $187.09 $98,075 - $110,383
590 Added 190.32%
900 $152,000
Q2 2019

Aug 13, 2019

SELL
$164.61 - $190.37 $2.88 Million - $3.33 Million
-17,472 Reduced 98.26%
310 $57,000
Q1 2019

May 15, 2019

SELL
$163.73 - $194.7 $1.57 Million - $1.86 Million
-9,563 Reduced 34.97%
17,782 $3.27 Million
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $4.15 Million - $5.26 Million
27,345 New
27,345 $4.53 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.